Last reviewed · How we verify
A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults - a 26-week, Randomised, Open, Parallel Group Multicentre Study
The purpose of the study is to compare the efficacy of a flexible dose of Symbicort with conventional stepwise treatment according to asthma treatment guidelines in patients with persistent asthma.
Details
| Lead sponsor | AstraZeneca |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 1000 |
| Start date | 2004-09 |
| Completion | 2006-01 |
Conditions
- Asthma
Interventions
- Budesonide/formoterol Turbuhaler
Primary outcomes
- Time to first severe asthma exacerbation
Countries
France